|
|
|
|
| LEADER |
03935nam a2200397 u 4500 |
| 001 |
EB000943860 |
| 003 |
EBX01000000000000000737450 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 100 |
1 |
|
|a Wolff, Tracy
|
| 245 |
0 |
0 |
|a Folic acid supplementation for the prevention of neural tube defects
|h Elektronische Ressource
|b an update of the evidence for the U.S. Preventive Services Task Force
|c Tracy Wolff, Catherine Takacs Witkop, Therese Miller, Shamsuzzoha B. Syed
|
| 260 |
|
|
|a Rockville (MD)
|b Agency for Healthcare Research and Quality (US)
|c [2009], 2009
|
| 300 |
|
|
|a 1 online resource
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Clinical Trials as Topic
|
| 653 |
|
|
|a Folic Acid / therapeutic use
|
| 653 |
|
|
|a Folic Acid / administration & dosage
|
| 653 |
|
|
|a Neural Tube Defects / drug therapy
|
| 653 |
|
|
|a Neural Tube Defects / prevention & control
|
| 653 |
|
|
|a Epidemiologic Studies
|
| 700 |
1 |
|
|a Witkop, Catherine Takacs
|e [author]
|
| 700 |
1 |
|
|a Miller, Therese
|e [author]
|
| 700 |
1 |
|
|a Syed, Shamsuzzoha B.
|e [author]
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 710 |
2 |
|
|a U.S. Preventive Services Task Force
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Evidence syntheses
|
| 500 |
|
|
|a Title from HTML header. - "May 2009."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK43412
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Differences in study type and methods prevent the calculation of a summary of the reduction in risk. The one included study on harms reported that the association of twinning with folic acid intake disappeared after adjusting for in vitro fertilization and for underreporting of folic acid intake. LIMITATIONS: There is limited evidence on dose. We found no evidence on the potential harm of masking vitamin B12 deficiency in women of childbearing age. Our search focused on NTDs and therefore does not provide a comprehensive review of the effects of folic acid on all possible outcomes. CONCLUSIONS: New observational evidence supports previous RCT evidence that folic acid-containing supplements reduce the risk of NTD-affected pregnancies. The association of folic acid use with twin gestation may be confounded by fertility interventions including ovulation stimulation and in vitro fertilization
|
| 520 |
|
|
|a STUDY SELECTION: English language studies were selected to answer the following two questions: Does folic acid supplementation in women of childbearing age reduce the risk of a pregnancy affected by a neural tube defect? Does folic acid supplementation in women of childbearing age increase the risk of any harmful outcomes for either the woman or the infant? The following study types were selected: for potential benefits of folic acid--randomized, controlled trials (RCTs), case-control studies, cohort studies, systematic reviews and meta-analyses; for potential harms of folic acid--RCTs, case-control studies, systematic reviews, meta-analyses, and large observational studies. DATA EXTRACTION: All studies were reviewed, abstracted, and rated for quality using predefined U.S. Preventive Services Task Force criteria. DATA SYNTHESIS: Four observational studies reported benefit, in reduction of risk of NTD associated with folic acid-containing supplements.
|
| 520 |
|
|
|a BACKGROUND: Neural tube defects (NTDs) are among the most common birth defects in the United States. PURPOSE: To update the evidence on folic acid supplementation in women of childbearing age for the prevention of neural tube defects in their offspring. DATA SOURCES: MEDLINE and Cochrane Library searches (from January 1995 through November 2007), recent systematic reviews, reference lists of retrieved articles, and expert suggestions.
|